First Phosphate Income Statement

Financials in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 28, 2026	Feb '25 Feb 28, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022
Selling, General & Admin	3.88	1.46	2.81	1.38	0.05
Research & Development	1	0.47	0.43	-	-
Operating Expenses	24.42	8.37	8.41	3.11	0.05
Operating Income	-24.42	-8.37	-8.41	-3.11	-0.05
Interest Expense	-0.33	-0.4	-0.07	-	-
Interest & Investment Income	0.26	0.14	0.06	-	-
Currency Exchange Gain (Loss)	0	0.01	-0	-	-
Other Non Operating Income (Expenses)	1.05	0.97	0.2	-0.08	-0.01
EBT Excluding Unusual Items	-23.44	-7.65	-8.23	-3.2	-0.06
Gain (Loss) on Sale of Investments	-	0.03	0.05	-	-
Asset Writedown	-	-	-0.11	-	-
Other Unusual Items	-	-	-	0.01	-
Pretax Income	-23.44	-7.63	-8.29	-3.19	-0.06
Net Income	-23.44	-7.63	-8.29	-3.19	-0.06
Net Income to Common	-23.44	-7.63	-8.29	-3.19	-0.06
Shares Outstanding (Basic)	114	78	55	25	1
Shares Outstanding (Diluted)	114	78	55	25	1
Shares Change (YoY)	47.40%	40.36%	117.70%	4137.78%	235.86%
EPS (Basic)	-0.21	-0.10	-0.15	-0.13	-0.11
EPS (Diluted)	-0.21	-0.10	-0.15	-0.13	-0.11
Free Cash Flow	-21.24	-8.32	-3.7	-5.18	-0.03
Free Cash Flow Per Share	-0.19	-0.11	-0.07	-0.20	-0.04
EBITDA	-24.41	-	-	-	-
D&A For EBITDA	0.01	-	-	-	-
EBIT	-24.42	-8.37	-8.41	-3.11	-0.05